iTeos Therapeutics ITOS 深 沪
已收盘 09-19 16:00:00 美东时间
11.22
-0.370
-3.19%
华盛通- 最 高11.74
- 今 开11.52
- 成交量 83.19万股
- 最 低 11.20
- 昨 收 11.59
- 总市值 4.02亿
- 52周最高 18.75
- 市盈率 静 --
- 换手率 2.32%
- 52周最低 8.20
- 委 比 88.71%
- 总股本 3584.31万
- 历史最高 52.43
- 量 比 0.42
- 振 幅 4.66%
- 历史最低 8.20
- 每 手 1
- 风险率 2.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Crude Oil Surges Over 1%; Instil Bio Shares Plunge
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
09-17 00:31
Market-Moving News for September 16th
NCNA: 282% | NuCana Presented Final Data From Phase 2 Nutide:701 Study At ESMO Congress On NUC-7738 In Combination With Pembrolizumab For Patients With Metastatic Melanoma Who Were Refractory To Or Had Relapsed On
09-16 20:08
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market tradin...
09-16 18:07
iTeos Therapeutics GAAP EPS of -$0.18
iTeos Therapeutics press release (NASDAQ:ITOS): Q2 GAAP EPS of -$0.18. The Company’s cash, cash equivalents, and investments position was $679.4 million as of June 30, 2024, as compared to $677.5 mill...
08-08 20:26
iTeos Therapeutics appoints David Feltquate as chief medical officer
iTeos Therapeutics (NASDAQ:ITOS) said it has appointed David Feltquate as its chief medical officer. Feltquate has nearly 20 years of immuno-oncology clinical development, translational medicine, and ...
08-05 19:20
罗氏抗TIGIT疗法未达主要目标 Compugen (CGEN.US)等生物科技股盘前遭重创
瑞士制药巨头罗氏公司(Roche)正在积极开发的一种类似药物在2/3期临床试验中失败后，在美股上市的一些生物科技公司所开发的一类新型抗癌药物(被称为新型的“抗TIGIT疗法”)在美股盘前的股价均明显下跌。
07-05 20:35
Roche's setback in lung cancer trial sends anti-TIGIT developers lower
Biotechs developing a class of novel cancer drugs called anti-TIGIT therapies turned lower in the premarket Friday after a similar drug developed by Roche (OTCQX:RHHBY) failed in a Phase 2/3 clinical ...
07-05 19:18
Every day is Sushi Day at Kroger
Retailer is serving up millions of fresh sushi rolls each year CINCINNATI, June 13, 2024 /PRNewswire/ -- The Kroger Co. (NYSE: KR), America's largest sushi retailer, is celebrating Internati...
06-14 02:15
J.P. Morgan Remains a Buy on iTeos Therapeutics (ITOS)
In a report released today, Brian Cheng from J.P. Morgan maintained a Buy ratin...
06-06 05:27
We Think ITeos Therapeutics, Inc.'s (NASDAQ:ITOS) CEO Compensation Package Needs To Be Put Under A Microscope
Key Insights iTeos Therapeutics to hold its Annual General Meeting on 11th of...
06-05 06:54
